Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (585)	4/30/2001 9:16:32 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1784

>> Structural BioInformatics obviates X-Ray crystallography << "is trying to obviate" <g> >> Anybody else want to chip in? << I'm useless. Plus, trying to get out the door for a biotech field trip....... won't be around from Wednesday to Monday.

To: tuck who wrote (585)	5/1/2001 12:20:27 AM
From: keokalani'nui	Read Replies (2) \| Respond to of 1784

Tuck, that the price is cheaper doesn't change my mind--though it does make it more likely that a small percentage pop could be an advantageous investment return. Personally, I don't want to own anything that does not have a long-term trajectory, especially in trickle which trades slope for safety. Should Trickle? Maybe so. Mcls hasn't even built its launch pad...and regrettably it has some rock hard financing. I would worry, with the LT debt in place, they likely misjudged how much it all costs, how long it all takes, how much time they get at Argonne, and how tight with a buck are all its few clients. Sh*t, I dunno anything anyway and don't know why I am slamming a stock so inexpensive. I did eMail them about the other 39 resolved structures, but have not heard back. Yes I am aware how easy it is to ignore eMail and a phone follow up is coming. Its just not my fav....so it doesn't get done. Knowing about the 39 would make it a much more appealing investment. Wilder